Bioactive molecules in the <10kDa fraction of the Lactobacillus helveticus R0389 and Lactobacillus rhamnosus R0011 secretomes down-regulate IL-8 production by HT-29 human intestinal epithelial cells induced by pro-inflammatory stimuli (MUC9P.752)

Abstract

Abstract The human gut microbiome has recently been associated with maintaining intestinal epithelial cell (IEC) homeostasis at the gastrointestinal interface by modulating host mucosal immune responses through varied mechanisms. The aim of this study was to compare the immunomodulatory activities of the L. helveticus R0389 and L. rhamosus R0011 secretomes on IEC. The human IEC line HT-29 was activated with a range of innate immune stimulants, to allow delineation of differential effects of the secretomes on Interleukin-8 (IL-8) production induced by varied stimuli. HT-29 IEC were co-incubated with either L. helveticus R0389 or L. rhamnosus R0011 secretomes and one of the following pro-inflammatory stimuli: interleukin 1-β (IL-1β), tumor necrosis factor-α (TNF-α); the toll-like receptor (TLR) agonists poly (I:C) (TLR3) or lipopolysaccharide (LPS) (TLR4), and alterations in IL-8 production were measured via enzyme-linked immunosorbant assay (ELISA). The L. helveticus R0389 and L. rhamnosus R0011 secretomes were also subjected to size fractionation to determine the size of the bioactive constituent of the secretome. Down-regulation of IL-8 was observed in HT-29 IEC co-incubated with the <10kDa fraction of the L. helveticus R0389 secretome or the L. rhamnosus R0011 secretome, for all of the innate immune stimulants tested. These results suggest that both Lactobacilli may secrete a low molecular weight bioactive molecule that modulates host immune activity by IEC.